# Serial PET MPI in Patients Undergoing Cancer Treatment

> **NCT05913999** · — · ENROLLING_BY_INVITATION · sponsor: **University of California, Los Angeles** · enrollment: 60 (estimated)

## Conditions studied

- Cancer
- Chemotherapeutic Toxicity
- Coronary Artery Disease
- Coronary Microvascular Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05913999
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-06-01
- **Primary completion:** 2027-07-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-08-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05913999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05913999, "Serial PET MPI in Patients Undergoing Cancer Treatment". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05913999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*